![](/img/cover-not-exists.png)
A randomized, placebo-controlled, phase 1 study to evaluate the effects of TAK-063 on ketamine-induced changes in fMRI BOLD signal in healthy subjects
Yurgelun-Todd, Deborah A., Renshaw, Perry F., Goldsmith, Paul, Uz, Tolga, Macek, Thomas A.Journal:
Psychopharmacology
DOI:
10.1007/s00213-019-05366-1
Date:
November, 2019
File:
PDF, 1.67 MB
2019